Chemical makers cut back amid uncertainty

The second quarter was a challenging one for US and European chemical makers. Sales crept up, but lower selling prices derailed the industry’s efforts to post substantive gains from a year ago. With expectations of sluggish business for the remainder of the year, chemical firms are taking matters into their own hands by cutting costs and trimming unprofitable assets and questionable projects. Results at the world’s largest chemical maker, BASF, were mixed. Sales declined by 6.9% from the prior-year quarter, but earnings excluding special items rose by 29.2%. “We saw a continuation of the dynamics of the first quarter, marked by positive volume momentum across most of our businesses,” BASF CEO Markus Kamieth says in prepared remarks. Lower selling prices for its products drove the sales declines. A bright spot for the diversified German company was its chemical business, which saw a 6.0% increase in sales driven largely by stronger

Authors

Publication Details

Journal
C&EN Global Enterprise
Published
2024-08-19
DOI
https://doi.org/10.1021/cen-10225-buscon3
Primary Topic
Biotechnology and Related Fields
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chemical makers cut back amid uncertainty

Alex Tullo
C&EN Global Enterprise
Biotechnology and Related Fields
article

Chemical makers cut back amid uncertainty

Alex Tullo
article en

Abstract

The second quarter was a challenging one for US and European chemical makers. Sales crept up, but lower selling prices derailed the industry’s efforts to post substantive gains from a year ago. With expectations of sluggish business for the remainder of the year, chemical firms are taking matters into their own hands by cutting costs and trimming unprofitable assets and questionable projects. Results at the world’s largest chemical maker, BASF, were mixed. Sales declined by 6.9% from the prior-year quarter, but earnings excluding special items rose by 29.2%. “We saw a continuation of the dynamics of the first quarter, marked by positive volume momentum across most of our businesses,” BASF CEO Markus Kamieth says in prepared remarks. Lower selling prices for its products drove the sales declines. A bright spot for the diversified German company was its chemical business, which saw a 6.0% increase in sales driven largely by stronger

C&EN Global EnterpriseVol. 102(25)
Openalex Percentile: Top 80%
Biotechnology and Related Fields
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.